July 14,2006
Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs
Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.
Next Article Previous Article
Recent News
- Crapo Announces Social Security, USTR, HHS Nominations Hearing
- Finance Committee Advances Treasury, IRS Nominations
- Crapo Statement at Executive Session to Consider Treasury, IRS Nominations
- Crapo Announces Executive Session to Consider Treasury, IRS Nominations
- Crapo Statement at Hearing on Taxation of Digital Assets